Lots of HIV R&D, but only 0.1% for developing-country specific versions (G-FINDER)

“Total R&D funding for HIV/AIDS was US$1.08 billion, with US$692 million (63.9%) directed to vaccines, US$200 million (18.4%) to microbicides, and US$176 million (16.2%) to basic research. Less than US$1 million (0.1%) was invested in development of HIV drugs targeted at developing world needs, such as paediatric formulations and fixed-dose antiretroviral combinations (Figure 2).

PLoS Medicine 2009
[First G-FINDER report]


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s